Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MTNR1A | P48039 | 8/20 | 0.38 |
| ▸ | MTNR1B | P49286 | 8/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | ACACB | O00763 | 6/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | THRB | P10828 | 1/20 | 0.34 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.34 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.34 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.34 |
| ▸ | THPO | P40225 | 1/20 | 0.34 |
| ▸ | RECQL | P46063 | 1/20 | 0.34 |
| ▸ | BLM | P54132 | 1/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
| ▸ | ACACA | Q13085 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21513624 | 0.80 | ACACB (0.37) | MTNR1AMTNR1BALDH1A1ACACBKDM4E | |
| SCHEMBL24459288 | 0.79 | ACACB (0.39) | MTNR1AMTNR1BALDH1A1ACACBKDM4E | |
| SCHEMBL13136108 | 0.79 | ACACB (0.39) | MTNR1AMTNR1BALDH1A1ACACBKDM4E | |
| SCHEMBL21513217 | 0.78 | ACACB (0.30) | ACACB | |
| SCHEMBL16316801 | 0.76 | ACACB (0.40) | MTNR1AMTNR1BALDH1A1ACACB | |
| SCHEMBL21496518 | 0.74 | CA12 (0.36) | ALDH1A1ACACBKDM4EMAPTTHRB | |
| SCHEMBL19021857 | 0.74 | HDAC4 (0.39) | MTNR1AMTNR1BALDH1A1ACACB | |
| SCHEMBL9816058 | 0.73 | — | — | |
| SCHEMBL14544609 | 0.72 | ACACB (0.42) | MTNR1AMTNR1BACACB | |
| SCHEMBL11685720 | 0.72 | ALDH1A1 (0.30) | ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3781661-B1 | TETRAACETYLDIAMINE AND TRIACETYLDIAMINE DERIVATIVES USEFUL AS BLEACH ACTIVATORS | DOW GLOBAL TECHNOLOGIES LLC (US) | 2024-03-13 | — | — | EP | disclosed |
| US-11525106-B2 | Tetraacetyldiamine and triacetyldiamine derivatives useful as bleach activators | DOW GLOBAL TECHNOLOGIES LLC (US) | 2022-12-13 | — | — | US | disclosed |
| US-11525106-B2 | Tetraacetyldiamine and triacetyldiamine derivatives useful as bleach activators | DOW GLOBAL TECHNOLOGIES LLC (US) | 2022-12-13 | — | — | US | disclosed |
| US-20210155877-A1 | TETRAACETYLDIAMINE AND TRIACETYLDIAMINE DERIVATIVES USEFUL AS BLEACH ACTIVATORS | DOW GLOBAL TECHNOLOGIES LLC | 2021-05-27 | — | — | US | disclosed |
| US-20210155877-A1 | TETRAACETYLDIAMINE AND TRIACETYLDIAMINE DERIVATIVES USEFUL AS BLEACH ACTIVATORS | DOW GLOBAL TECHNOLOGIES LLC | 2021-05-27 | — | — | US | disclosed |
| EP-3781661-A1 | TETRAACETYLDIAMINE AND TRIACETYLDIAMINE DERIVATIVES USEFUL AS BLEACH ACTIVATORS | Dow Global Technologies, LLC (US) | 2021-02-24 | — | — | EP | disclosed |
| CN-112400014-A | Tetraacetyldiamine and triacetyldiamine derivatives useful as bleach activators | 陶氏环球技术有限责任公司 | 2021-02-23 | — | — | CN | disclosed |
| WO-2019204184-A1 | TETRAACETYLDIAMINE AND TRIACETYLDIAMINE DERIVATIVES USEFUL AS BLEACH ACTIVATORS | DOW GLOBAL TECHNOLOGIES LLC (US) | 2019-10-24 | — | — | WO | disclosed |
| WO-2019204184-A1 | TETRAACETYLDIAMINE AND TRIACETYLDIAMINE DERIVATIVES USEFUL AS BLEACH ACTIVATORS | DOW GLOBAL TECHNOLOGIES LLC (US) | 2019-10-24 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11525106-B2 | Tetraacetyldiamine and triacetyldiamine derivatives useful as bleach activators | AADAC, DLAT, NAT10 | MTNR1A 3848/4885MTNR1B 3876/4885ALDH1A1 1218/4885 |
| US-20210155877-A1 | TETRAACETYLDIAMINE AND TRIACETYLDIAMINE DERIVATIVES USEFUL AS BLEACH ACTIVATORS | AADAC, DLAT, NAT10 | MTNR1A 3848/4885MTNR1B 3876/4885ALDH1A1 1218/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.